Y. Fradet

Publication List Details

Period

1996 - 1996

Number

15

Co-Authors

Alterations in phenotypic biochemical markers in bladder epithelium during tumorigenesis.

Rao, J Y, Hemstreet, G P, Hurst, R E, Bonner, R B, Jones, P L, Min, K W, ...

Phenotypic biochemical markers of oncogenesis and differentiation were mapped in bladder biopsies to investigate changes that occur in bladder tumorigenesis and to identify markers for increased...

Polymorphic expression of a human superficial bladder tumor antigen defined by mouse monoclonal antibodies.

Fradet, Y, Islam, N, Boucher, L, Parent-Vaugeois, C, Tardif, M

Three mouse monoclonal antibodies (mAbs), which define a highly restricted antigen, were obtained by simultaneous immunizations with superficial papillary bladder tumor cells and mouse polyclonal...

Cell surface antigens of human bladder cancer defined by mouse monoclonal antibodies.

Fradet, Y, Cordon-Cardo, C, Thomson, T, Daly, M E, Whitmore, W F, Lloyd, K O, ...

Mouse monoclonal antibodies were obtained by immunization with cultured human bladder cancer or lysates of bladder papilloma. They identify 11 distinct antigenic systems as defined by serological...

Biochemical analysis of a bladder-cancer-associated mucin: structural features and epitope characterization.

Bergeron, A, LaRue, H, Fradet, Y

Three monoclonal antibodies (mAbs), M344, M300 and M75, were shown to define a unique tumour-associated antigen (TAA) of superficial bladder tumours. The antigenic determinants are expressed on a...

Efficacy and safety of finasteride therapy for benign prostatic hyperplasia: results of a 2-year randomized controlled trial (the PROSPECT study). PROscar Safety Plus Efficacy Canadian Two year Study.

Nickel, J C, Fradet, Y, Boake, R C, Pommerville, P J, Perreault, J P, Afridi, S K, ...

OBJECTIVE: To evaluate the efficacy and safety of 2 years' treatment of moderate benign prostatic hyperplasia (BPH) with finasteride. DESIGN: Double-blind, parallel-group, placebo-controlled,...

Alterations in phenotypic biochemical markers in bladder epithelium during tumorigenesis.

Rao, J Y, Hemstreet, G P, Hurst, R E, Bonner, R B, Jones, P L, Min, K W, ...

Phenotypic biochemical markers of oncogenesis and differentiation were mapped in bladder biopsies to investigate changes that occur in bladder tumorigenesis and to identify markers for increased...

Polymorphic expression of a human superficial bladder tumor antigen defined by mouse monoclonal antibodies.

Fradet, Y, Islam, N, Boucher, L, Parent-Vaugeois, C, Tardif, M

Three mouse monoclonal antibodies (mAbs), which define a highly restricted antigen, were obtained by simultaneous immunizations with superficial papillary bladder tumor cells and mouse polyclonal...

Cell surface antigens of human bladder cancer defined by mouse monoclonal antibodies.

Fradet, Y, Cordon-Cardo, C, Thomson, T, Daly, M E, Whitmore, W F, Lloyd, K O, ...

Mouse monoclonal antibodies were obtained by immunization with cultured human bladder cancer or lysates of bladder papilloma. They identify 11 distinct antigenic systems as defined by serological...

Biochemical analysis of a bladder-cancer-associated mucin: structural features and epitope characterization.

Bergeron, A, LaRue, H, Fradet, Y

Three monoclonal antibodies (mAbs), M344, M300 and M75, were shown to define a unique tumour-associated antigen (TAA) of superficial bladder tumours. The antigenic determinants are expressed on a...

Efficacy and safety of finasteride therapy for benign prostatic hyperplasia: results of a 2-year randomized controlled trial (the PROSPECT study). PROscar Safety Plus Efficacy Canadian Two year Study.

Nickel, J C, Fradet, Y, Boake, R C, Pommerville, P J, Perreault, J P, Afridi, S K, ...

OBJECTIVE: To evaluate the efficacy and safety of 2 years' treatment of moderate benign prostatic hyperplasia (BPH) with finasteride. DESIGN: Double-blind, parallel-group, placebo-controlled,...

Immunopathologic analysis of human urinary bladder cancer. Characterization of two new antigens associated with low-grade superficial bladder tumors.

Cordon-Cardo, C., Wartinger, D. D., Melamed, M. R., Fair, W., Fradet, Y.

The authors have further characterized the normal human tissue distribution and tumor expression of two highly restricted tumor-associated antigens, detected by mouse monoclonal antibodies M344 and...

L'Echelle Internationale de Cotation des Symptômes Prostatiques. Evaluation de la réactivité d'une adaptation française.

Moisan, J., Grégoire, J. P., Labrecque, M. G., Fradet, Y.

OBJECTIVE: To evaluate the usefulness of a French-language version of the International Prostate Symptom Scale (I-PSS) by measuring, on this scale and on the quality of life index, the scores of...